OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

Conference Proceedings

B Solomon, P Kok, A Livingstone, S Yip, C Brown, S Dawson, S Wong, N Pavlakis, M Stockler

JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2017